Biotech Benefits as Companies Race to Cure Coronavirus
May 26, 2020 at 12:42 PM EDT
There’s no denying biotechnology ETFs are benefiting from the race to cure and treat and the novel coronavirus. Just look at the VanEck Vectors Biotech ETF (BBH), which is higher by more than 7% over just the past month. BBH seeks to replicate as closely as possible, before fees and expenses,...